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Abstract
Background: Kawasaki disease is a systemic vasculitis and may affect cerebral function acutely.
The aim of the present study was to measure a number of behaviour and social parameters within
a cohort of Kawasaki disease patients.
Methods: Parents of children with past diagnosis of Kawasaki disease were recruited to complete
several behaviour screening questionnaires. Sixty five sets of questionnaires relating to the patient
cohort received were eligible for inclusion. Two control groups were used, a hospital (HC) control
and a sibling control (SC) group.
Results: 40% of the Kawasaki disease group showed elevated internalising scores in the clinical or
borderline-clinical range. This compared with 18% of hospital controls and 13% of sibling controls.
Additionally, the Kawasaki disease (KD) group were shown to be experiencing greater overall total
difficulties when compared with the controls (KD 13.7, HC 8.6, SC 8.9). The KD group attained
higher behavioural scores within the internalising sub-categories of somatic problems (KD 61, HC
57, SC 54) and withdrawn traits (KD 56, HC 53, SC 51). The KD group were also shown to be
suffering more thought problems (KD 57, HC 53, SC 50) compared with the controls. Further
difficulties relating to conduct (KD 3.3, HC 1.4) and social interactions (KD 6.7, HC 8.3) are also
highlighted for the KD group compared with hospital controls. Positron emission tomograms were
performed on nine patients to investigate severe behavioural problems. Three showed minor
changes, possibly a resolving cerebral vasculopathy.
Conclusion: Kawasaki disease can be associated with significant behavioural sequelae. This is an
important consideration in the long-term follow up and referral to a clinical psychologist may be
necessary in selected patients.
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Background
In 1967, Tomisaku Kawasaki first described an illness in
children called 'acute febrile mucocutaneous lymph node
syndrome' [1]. It has now become more commonly
known as Kawasaki disease. The diagnostic criteria accord-
ing to the Centres for Disease Control (Atlanta) are laid
out below. Fever of 5 days plus 4 out of the 5 remaining
criteria [2], or fever plus coronary artery aneurysms at
echocardiography and 3 additional criteria are generally
required for a diagnosis of Kawasaki disease to be made
[3] (see table 1).
Cardiac complications can occur which include coronary
artery aneurysms, which have been documented as devel-
oping during the illness in 25% of patients treated with
aspirin alone (determined at echocardiography) [3,4].
Treatment with intravenous gammaglobulin and aspirin
has been shown to reduce this incidence considerably
[5,6].
Pathologically, Kawasaki disease is a multisystem vasculi-
tis affecting small and medium sized arteries. Inflamma-
tion is progressive, initially mild affecting only the
subendothelium and progressing to a severe panarteritis
of the coronary arteries. Injured arteries are weakened and
thus aneurysms may form as a result [3].
Neurological and psychological complications associated
with Kawasaki disease have also been noted, although
reports in this area are limited. Neurological complica-
tions include aseptic meningitis occurring in 26–50% of
cases as well as facial nerve palsy, sensorineural hearing
loss, hemiplegia, cerebral infarction and severe lethargy,
which have all been reported in various case studies [3-6].
Amano and Hazama have examined histological speci-
mens from 30 Kawasaki disease patients and found evi-
dence of the occurrence of endoarteritis and periarteritis
within the brain [3] and it is likely that many of the CNS
complications are secondary to such a process of cerebral
vasculitis [8].
Extreme irritability is a well documented observation seen
in children during the acute phase of the illness, which
generally resolves after treatment. However, a recent study
performed by King and workers have reported that behav-
ioural problems may develop or persist once the acute
phase of the illness has passed and then continue for
months or years after the initial illness [7]. The study con-
sisted of 32 patients with Kawasaki disease in the USA and
used siblings as controls. They demonstrated that post
acute Kawasaki disease patients had a significantly greater
tendency to internalising and attentional behavioural
problems, although no firm aetiology was uncovered [7].
However, this study was somewhat limited as it was car-
ried out on a relatively small cohort and did not include a
control group of patients that had been hospitalised for a
similar time period.
It is these behavioural sequelae that we are interested in as
we have documented many cases in clinic of reported
behavioural problems persisting for months and years
after the initial episode of Kawasaki disease.
We initially set out to screen for potential behavioural
problems within a British patient cohort. 123 children
with a past diagnosis of Kawasaki disease reviewed in a
long term Kawasaki disease follow up clinic were
included. Parents were asked at time of their visit to
answer a series of questions relating to behaviour and cer-
tain aspects of their child's disease. Additionally, 142
questionnaires used by a national Kawasaki disease parent
support group were reviewed retrospectively. All the data
was collected between 1996–1999, with 265 children
being reviewed in total. The questions in clinic and within
the help group questionnaire were derived from Rutter's B
questionnaire, with the aim to identify significant changes
in physical and psychological health as perceived by the
child's carer [3]. The results demonstrated that 90 of the
children (34%) suffered from behavioural changes, last-
ing for more than one year following their recovery from
the acute stages of Kawasaki disease. These behavioural
problems were significant enough to lead to consultation
with an educational psychologist, clinical psychologist or
a GP. The behavioural problems recognised in the data
included hyperactivity, decreased concentration,
increased aggression and emotional lability.
Based on these initial results, we therefore set out to inves-
tigate these behavioural difficulties in a more detailed and
quantitative fashion within a British Kawasaki disease
patient cohort.
There is nothing in the current management protocol that
is aimed at addressing behavioural difficulties, nor in the
advice given to parents. Finding a significant correlation
between Kawasaki disease and behavioural sequelae
would provide the basis for an important added dimen-
sion in the long-term management of the disease. We
would hope to provide a greater insight and awareness
into behavioural sequelae, which would lead to earlier
referrals to a child psychologist where necessary, more
specific advice to the parents on how best to manage their
child as well as providing reassurance that the child's
behavioural difficulties may be within the normal seque-
lae of Kawasaki disease.
Methods
A retrospective cohort study was selected as the most
appropriate method in view of the uncommon frequency
of Kawasaki disease within the UK population. Parents ofBMC Pediatrics 2005, 5:14 http://www.biomedcentral.com/1471-2431/5/14
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children who had been seen in clinic between 1995 –
2001 were contacted by telephone and informed verbal
consent gained. When parents could not be contacted by
phone, a detailed covering letter explained the nature of
the research was sent out and parents were invited to
respond. The study was approved by the Local Ethics
Committee.
The Kawasaki disease patient group (KD group)
Inclusion criteria for this stage of the research were: (a) all
patients aged under 18 years at time of diagnosis and at
the time of the study were between 3 to 18 years old; (b)
A diagnosis of KD formally having been reached accord-
ing to the criteria in table 1; (c) sufficient level of English
spoken by parent/carer to understand questionnaires; and
(d) no history of CNS dysfunction unrelated to KD, or any
other history of severe illness.
112 sets of questionnaires were sent out to parents. 77
questionnaires were received and 65 were suitable for
inclusion according to our predetermined criteria.
Controls
Two control groups with different characteristics were
used. The first consisted of previous hospital inpatients
who had stayed in hospital for a short period and under-
gone a cardiac catheterisation, with follow-up at regular
intervals. This group was chosen in order to control for the
effects of a hospital stay on child behaviour. Patients who
had subsequently progressed to surgery, or suffered from
an unrelated CNS disorder or other chronic illness were
not deemed suitable for inclusion. These controls were
matched to the KD group, as best as possible, according to
age and sex. 47 sets of questionnaires were sent out and 23
were returned completed.
The second control group consisted of siblings of the KD
group matched for age and sex, as best as possible. This
control group was selected in order to control for the
influence of genetics and environment on child behav-
iour. 31 sets of questionnaires were sent out and 17 were
returned.
Details of the groups are included in Table 1.
Data collection instruments
Mothers of patients were sent out a series of psychological
screening questionnaires for behavioural difficulties,
which they were invited to complete. The questionnaire
set comprised: the Child Behaviour Check List – CBCL/4–
18 (Achenbach 1991) [13]; Strengths & Difficulties Ques-
tionnaire (Goodman 1997) [14], and the Parenting Stress
Index – PSI, (Abidin 1983) [15]. A general information
sheet was also devised for inclusion with the
questionnaires.
The Child Behaviour Check List (CBCL) tests the parental
reports of a child's competencies and quantifies behav-
ioural and emotional problems along predetermined cat-
egories. It has a one week test-retest reliability of r = 0.93
[13]. The CBCL was used to obtain standardised reports
from parents on behavioural and emotional problems for
their children. The CBCL contains 120 problems items
and measures in two broad categories: Internalising prob-
lems (consisting of the scales: anxious/depressed, somatic
complaints and withdrawn behaviour) and Externalising
complaints (aggressive, and delinquent behaviour). Addi-
tional scales of social problems, thought problems and
attention problems are also included.
The parenting stress index (PSI) short form is designed to
measure stresses occurring within the parent-child rela-
tionship and provides insight as to whether any difficul-
ties originate from the parent, the child or their
interaction. It uses the following categories; Total stress,
Parental distress, Parent child dysfunctional interaction,
and Difficult child. Also, scores for defensive responding
were recorded.
Table 1: Criteria necessary to confirm diagnosis of Kawasaki disease [2]
Criteria Description
Fever 5 days or more
AND
1. Conjunctivitis Bilateral
2. Mucous membrane changes of oropharynx Red cracked lips; strawberry tongue; or diffuse erythema
3. Changes of peripheral extremities Initially: erythema and oedema of palms and soles Convalescent stage: 
desquamation
4. Rash Polymorphous, non vesicular
5. Lymphadenopathy CervicalBMC Pediatrics 2005, 5:14 http://www.biomedcentral.com/1471-2431/5/14
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The Strengths and Difficulties Questionnaire (SDQ),
looks at behavioural, emotional and/or relationship
difficulties in children as well as a positive category that
rates social strengths and interactions. The SDQ provides
scores across 5 subscales; conduct, hyperactivity, emo-
tional, peer, and prosocial problems. It also generates a
total difficulty score.
Statistical analysis
One-way analyses of variance (ANOVA) were conducted
on each measure, with Bonferoni post hoc testing to
examine the differences between the groups. Fisher's Exact
Test was also employed to test the strength of a trend
within the groups. Means for each measure and standard
errors are given in Table 2.
Results
When asked by a single question, 56% of the Kawasaki
disease patient cohort were reported to be experiencing
minor to severe difficulties: emotionally, behaviourally or
socially. This compared with 35% of hospital controls and
46% of sibling controls. Looking at the scores on the
Child Behaviour Check List (CBCL), the KD group con-
sistently achieved higher mean behavioural scores than
the two control groups within all categories. (Table 2).
Significantly higher behavioural scores were attained by
the KD group within the withdrawn (P = 0.045) and
somatic (P = 0.030) categories, when compared with the
sibling controls (Table 3). This suggests a greater tendency
towards internalising behaviour within the KD group.
Indeed, 40% of the KD group fell within the clinical or
borderline range for internalising problems, compared
Table 2: Comparison between patient cohort and controls
KD patient Group Hospital Controls Sibling Controls
Number in group 65 23 17
Male : Female 1.6:1 0.9:1 0.9:1
Age on completion (mean, range) 7.38 (3–18) 8.95 (3–17) 8.68 (5–14)
Patient age at presentation with Kawasaki disease (median, range) 3.60 (0–14) N/A N/A
Number with coronary artery dilatations or aneurysms secondary to 
Kawasaki disease
13 (20%) N/A N/A
Reported difficulties (%) 56.3% 35.3% 46.2%
Table 3: Selected results, including all that were significant, from the scores to the questionnaires. FE = Fisher's exact test; SEM = 
Standard Error of Mean; † indicates P values less than 0.05 * indicates which control groups differed significantly (P < 0.05) from the 
KD group (see text for p values)
Category (mean, SEM) KD Group Hospital Controls Sibling controls Significance (ANOVA 
unless indicated)
CBCL/4–18
Internalising score in 
clinical or borderline range
40.0% 18.2% 12.5% 0.04 † (FE)
Externalising score in 
clinical or borderline range
26.2% 9.1% 25% 0.27 (FE)
Thought Problems 57.0 (1.06) 52.8 (1.19) 50.2 (1.74) * 0.03 †
Withdrawn 55.9 (0.96) 52.8 (1.19) 51.2 (0.82) * 0.02 †
Somatic 61.0 (1.27) 57.3 (1.63) 54.1 (1.81) * 0.02 †
Sex Problems 54.0 (1.10) 52.9 (1.57) 47.3 (1.28) * 0.01 †
Aggressive 56.5 (1.19) 52.0 (0.71) 52.6 (2.07) 0.05
Internal T score 53.4 (2.0) 48.5 (2.38) 44.1 (2.81) 0.05
Total T score 53.4 (1.73) 48.4 (2.45) 45.6 (3.36) 0.07
Strengths + Difficulties
Prosocial 6.7 (0.31) 8.3 (0.48) * 7.4 (0.63) 0.04 †
Conduct 3.3 (0.38) 1.4 (0.34) * 2.8 (0.73) 0.04 † 
Total Difficulties 13.7 (1.08) 8.6 (1.44) * 8.9 (1.93) 0.02 †
Parenting Stress Index
Difficult child (raw) 30.3 (1.52) 24.2 (1.47) 26.5 (2.80) 0.07BMC Pediatrics 2005, 5:14 http://www.biomedcentral.com/1471-2431/5/14
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with 18.2% of the hospital controls and 12.5% of the sib-
ling controls (FE = 0.040). No significant differences
between the groups were found for externalising prob-
lems. The KD group was found to have significantly
higher behavioural scores on the thought problem cate-
gory of the CBCL compared with the sibling control group
(P = 0.006). Thought problems reported included obses-
sions, compulsions as well as strange behaviour. Results
from the social and schooling categories of the CBCL did
not suggest any significant differences between the three
groups.
Scores on the Strengths and Difficulties Questionnaire
showed the KD group achieving higher mean scores than
both control groups within the four negative categories of
conduct, peer, emotional and hyperactivity. Along the
positive prosocial category (rating social strengths and
interactions) the KD group achieved a lower mean score
than both the control groups. The KD group were signifi-
cantly less helpful and considerate (prosocial category)
than the hospital control group (P = 0.045). The KD group
also experienced significantly more problems associated
with their conduct such as temper tantrums, disobedience
and argumentative behaviour when compared with the
hospital control group (P = 0.030). Greater total behav-
ioural difficulties experienced within the KD group when
compared to the hospital controls were also demonstrated
(P = 0.048).
On the Parental Stress Index, the KD group achieved
greater mean scores compared to the control groups.
However, the differences fell short of significance. There
may be a trend here towards a 'difficult' child being the
main source of stress within the parent-child relationship
(P = 0.084), but further research is required to confirm
this.
No significant differences were shown between the hospi-
tal control and the sibling control groups within any of
the questionnaires.
13 patients within the KD group were documented as suf-
fering or having suffered from coronary artery dilatation
or aneurysms secondary to their Kawasaki disease. No sig-
nificant differences or trends to significance were shown
when comparing the mean behavioural scores of the KD
group with dilatations/aneurysms and the KD group with-
out dilatations/aneurysms.
Furthermore, no significant differences or values
approaching significance were demonstrated when com-
paring age of onset of Kawasaki disease with mean behav-
ioural scores.
Discussion
Our initial indications that a significant number of chil-
dren experience behavioural sequelae in the short to
medium-term post Kawasaki disease was confirmed by
more detailed investigation. The KD group showed higher
scores on measures of behavioural and emotional difficul-
ties when compared with both control groups, with the
emergence of significant differences demonstrated
between the KD group and the controls across various cat-
egories of the questionnaires. The CBCL showed these sig-
nificant differences to exist between the KD group and the
sibling control group, whereas the SDQ showed signifi-
cant differences between the KD and the hospital control
group.
Like King et al. (2000) [7], we have shown a strong pre-
ponderance towards problems of an internalising nature
within the KD group. 40% of the KD group were shown to
have internalising scores in the clinical or borderline-clin-
ical range, representing an incidence greater than twice
that of the control groups. In line with this, significantly
higher scores were attained by the KD group compared to
sibling controls within the internalising sub-categories of
somatic problems and withdrawn traits. However, unlike
King et al., our results also highlight further difficulties
relating to thought and conduct existing within the KD
group.
Importantly for parents, no significant differences were
demonstrated between the groups with regard to partici-
pation in activities and hobbies, social interaction or per-
formance at school. This, hopefully could form the basis
of some reassuring parental advice.
However, despite the lack of any proven link between
adverse effects on the child's overall social and academic
performance, the high incidence of clinical and border-
line-clinical internalising behaviour should make the
paediatrician aware of the potential need for referral to a
clinical psychologist during long term management. On
account of the fact that internalising behaviour can be
harder to detect than overt externalising traits, some sim-
ple screening questions into the child's behaviour should
be posed to the parents during long-term follow up of
Kawasaki disease.
This study has a few potential sources of bias. The rela-
tively low return rate of the questionnaires raises the pos-
sibility of self selection bias. Bias originating from the
parent answers to the questionnaires may also exist.
Kawasaki disease is a relative rare disease with the poten-
tial for serious cardiac complications. The associated fears
and anxieties likely to be experienced by the parents may
serve to exaggerate any observed behavioural difficulties
in the minds of the parents. This would be reflected inBMC Pediatrics 2005, 5:14 http://www.biomedcentral.com/1471-2431/5/14
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higher than expected behavioural scores. However, the
CBCL has been argued to mitigate this bias and moreover,
Green et al (1998) suggest that the CBCL is in fact intrin-
sically conservative in discriminating mild emotional and
behavioural problems [16]. The relatively small size of the
groups, especially the controls, may have limited the
extent of the significant behavioural and emotional prob-
lems seen, and we would therefore expect to see more sig-
nificant results emerge should the size of the groups be
expanded.
Pathological associations
Kawasaki disease is a systemic vasculitis which seems to
have a predilection to coronary arteries, although it has
also been shown to affect the cerebral arteries. Evidence
suggesting the nature of the consequences arising from the
cerebral vasculopathy has come from a single-photon
emission computed-tomography study carried out on 21
children in Japan by Ichiyama and Nishikawa. They were
able to demonstrate localised cerebral hypoperfusion
occurring in 29% of the patients during the acute phase of
Kawasaki disease [17].
Systemic lupus erythematous is also a multi-organ sys-
temic vasculitis, which is known to affect the cerebral
nervous system (CNS), causing various neuropsychiatric
symptoms [18,19]. Multiple areas of hypoperfusion have
been shown on SPECT studies of lupus patients positive
for neuropsychiatric symptoms [20]. Interestingly, one
study of 35 patients by Colamussi et al. (1995) found that
in the absence of neuropsychiatric symptoms, uptake was
normal in nearly all of the patients, whereas hypoper-
fusion was demonstrated in most patients with severe
neuropsychiatric sequelae [21].
It is suggested that these areas of hypoperfusion docu-
mented within lupus and Kawasaki disease may be caused
by a process of cerebral vasculitis resulting in patchy
ischaemic areas. The damage to the CNS which is likely to
arise may then alter neurological function for some time
after the acute phase of the illness, and this would cer-
tainly provide one reasonable explanation for the behav-
ioural difficulties that have been shown to persist in the
medium to long-term.
Indeed, supporting evidence comes from Suzuki et al,
(2000) who suggested that the remodelling of coronary
aneurysms is a process that continues for many years after
the onset of the disease [22]. One might surmise that con-
tinued behavioural problems may be the result of a paral-
lel remodelling process occurring in the brain.
Thus, the evidence of CNS pathology adds further weight
to our belief that the behavioural changes arise secondary
to a cerebral vasculopathy, and are not merely due to the
psychological complications of an acute severe illness.
Further experimental evidence
In order to further investigate any identifiable CNS
pathology affecting the brain, active or otherwise, we have
performed PET (glucose and ammonium) and MRI scans
on 7 post Kawasaki disease patients with severe behav-
ioural difficulties (Table 4). In all seven cases these were
carried out at least 6 months after their last episode of
Kawasaki disease. Three of these patients were reported to
have slightly reduced uptake of tracer, occurring within
the occipital lobes, although other areas were also affected
in two of the cases. Although these minimal changes are
of uncertain significance, they could represent resolving
areas of cerebral hypoperfusion secondary to cerebral vas-
culitis that occurred during the acute phase of the disease.
An ethically approved study with a larger patient base
would be the next step to investigate these changes
further.
Summary
In conclusion, we have shown significant behavioural
sequelae can occur following acute Kawasaki disease.
Therefore, the paediatrician should bear in mind the
potential need for long term follow up of Kawasaki dis-
ease patients in clinic even in the absence of coronary
artery aneurysms. Parents can be told that behavioural dif-
Table 4: Cerebral PET scan results following acute Kawasaki disease
No. Year of Kawasaki disease PET scan result Date of PET scan
1 1997 Diffusely reduced uptake in occipital lobes and cerebellum 24/6/99
2 1999 Normal 20/9/00
3 1999 Asymmetry in occipital region lower on R side 20/3/00
4 1995 Normal 27/5/99
5 1997 Normal 20/5/99
6 1999 Slight reduction in posterior parietal and occipital lobes symmetrically. 28/10/99
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ficulties experienced may be within the normal sequelae
of the disease process and they can be reassured that they
do not appear to affect school performance to any signifi-
cant degree. However, a few probing questions should be
asked to flesh out other possible causes before any diffi-
culties are attributed to Kawasaki disease. The paediatri-
cian should consider referral to a clinical psychologist
where necessary. This may indeed prove to be a common
requirement in long-term management, when it is consid-
ered that 40% of the KD group in this study fell within the
clinical or borderline-clinical range for internalising
problems.
Future research should examine the behavioural difficul-
ties in greater detail, employing formal neuropsychiatric
testing. Additionally, further research in this area is
required to rule out other possible causes of behavioural
sequelae. In particular, standard treatment with aspirin
and intravenous gammaglobulin should be eliminated as
potential aetiological factors.
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